T. Rowe Price Health Sciences Portfolio

23LI9YJ7764IBT5W0K91

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: United States
Entity created: October 22, 2018

Address

Country: United States
Legal address: C/O CSC-LAWYERS INCORPORATING SERVICE COMPANY, 7 ST. PAUL STREET, SUITE 82021202 BALTIMOREUnited States (US-MD)
Head office: C/O T. ROWE PRICE ASSOCIATES, INC., 1307 POINT STREET21231 BALTIMOREUnited States (US-MD)

Identifier

LEI: 23LI9YJ7764IBT5W0K91
Registered: June 6, 2012 at 03:53 PM UTC
Last updated: August 6, 2026 at 06:30 PM UTC
Next renewal: August 22, 2027 at 12:00 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: EDGAR (RA000665)
Identifier: S000002083
Verified against: EDGAR (RA000665)
Verified as: S000002083
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

T. Rowe Price Associates, Inc.
Fund managerUnited States7HTL8AEQSEDX602FBU63
T. ROWE PRICE EQUITY SERIES, INC.
Umbrella fundUnited States549300U8GAQGX2UFFV03

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/23LI9YJ7764IBT5W0K91This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search